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any viral fusion–mediating glycoproteins couple
 
 
 
-helical bundle formation to membrane merger,
but have different methods for fusion activation.
To study paramyxovirus-mediated fusion, we mutated the
SV5 fusion (F) protein at conserved residues L447 and
I449, which are adjacent to heptad repeat (HR) B and bind
to a prominent cavity in the HRA trimeric coiled coil in the
fusogenic six-helix bundle (6HB) structure. These analyses
on residues L447 and I449, both in intact F protein and in
6HB, suggest a metamorphic region around these residues
M
 
with dual structural roles. Mutation of L447 and I449 to
aliphatic residues destabilizes the 6HB structure and atten-
uates fusion activity. Mutation of L447 and I449 to aromatic
residues also destabilizes the 6HB structure despite pro-
moting hyperactive fusion, indicating that 6HB stability
alone does not dictate fusogenicity. Thus, residues L447
and I449 adjacent to HRB in paramyxovirus F have distinct
roles in fusion activation and 6HB formation, suggesting
this region is involved in a conformational switch.
 
Introduction
 
Membrane fusion is a process central to biology that requires
both the precise triggering of macromolecular assemblies
and the metamorphosis of individual fusion protein ma-
chines. Membrane coalescence promoted by protein hairpin
formation is a fusion mechanism shared by the type I viral
fusion–mediating glycoproteins (vFGps) of retroviruses, len-
tiviruses, filoviruses, coronaviruses, orthomyxoviruses, and
paramyxoviruses (Skehel and Wiley, 2000; Eckert and Kim,
2001). Type I vFGps are homotrimeric proteins that have
to be cleaved by a protease to yield a metastable complex
of membrane-distal and membrane-anchored subunits (for
paramyxoviruses, the F
 
0
 
 precursor is cleaved to F
 
1
 
 
 
 
 
 F
 
2
 
; Fig.
1). The membrane-anchored subunits contain two hydro-
phobic domains, the fusion peptide and the transmembrane
(TM) domain, each one adjacent to one of two conserved
heptad repeat (HR) regions, designated HRA and HRB,
respectively. Upon triggering by low pH or by receptor/
coreceptor binding, the hydrophobic fusion peptide inserts
into the target membrane (Hernandez et al., 1996). The
native metastable state may also be triggered artificially by
destabilizing agents such as heat or urea and by mutation
(Ruigrok et al., 1986; Paterson et al., 2000; Wharton et al.,
2000). A transient prehairpin intermediate formed after
insertion of the fusion peptide into the target membrane is
susceptible to binding by peptides derived from the HRB
regions of some vFGps. The HRB-derived peptides are
thought to inhibit membrane fusion by preventing HRA
and HRB from refolding into the fusogenic six-helix bundle
(6HB) structure, which couples protein refolding directly to
membrane fusion (Melikyan et al., 2000; Russell et al.,
2001). In this structure, a homotrimeric coiled coil formed
by HRA is buttressed by three antiparallel COOH-terminal
chains (in most cases consisting of residues from an HRB
region) in an antiparallel fashion (Skehel and Wiley, 2000;
Eckert and Kim, 2001).
A tightly regulated mechanism of fusion activation requires
stabilization of the native metastable form to sequester the
fusion peptide and keep the HR regions apart until the target
membrane is within range. Influenza virus HA is the only
type I vFGp for which the metastable structure is known at
atomic resolution. The metastable structure of HA is stabi-
lized by multiple interactions between regions of the protein
that undergo a protein-refolding event associated with mem-
brane fusion, such as the fusion peptide and HRA (Daniels
et al., 1987; Bullough et al., 1994). Although a high resolution
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structure for the native metastable form of HIV gp41 has
not yet been obtained, mutational experiments have revealed
that some HR residues that stabilize the gp41 6HB also
affect the stability of the metastable gp120–gp41 complex
(Follis et al., 2002; Sanders et al., 2002).
Activation of most paramyxovirus F proteins at neutral
pH is thought to be triggered by a three-step process includ-
ing binding of the viral receptor-binding protein (RBP) HN
or H to its receptor, HN interacting with F, and the HN/F
interaction, leading to changes in F that mediate membrane
fusion (Crennell et al., 2000; for review see Lamb and Kola-
kofsky, 2001; Russell et al., 2001; Takimoto et al., 2002;
Colman and Lawrence, 2003). Most paramyxovirus F pro-
teins require coexpression of their homotypic RBP for effi-
cient fusion activity, and mutant RBPs have been discovered
that retain receptor-binding activity, but have reduced or
eliminated fusion-promotion activity (for review see Lamb
and Kolakofsky, 2001). However, the SV5 W3A strain F
protein mediates fusion when expressed alone, albeit to a
lesser extent than when coexpressed with HN (Paterson et
al., 1985). The anomalous HN-independent fusion activity
of SV5 W3A strain F has been mapped to P22 near the NH
 
2
 
terminus of F
 
2
 
 (Ito et al., 2000; Paterson et al., 2000; Tsuru-
dome et al., 2001), and HN-independent fusion by NDV F
results from an L289A mutation (Sergel et al., 2000) that is
located on the NDV F atomic structure between the fuso-
genic and 
 
 
 
-barrel domains (Chen et al., 2001; Fig. 1).
Moreover, the SV5 W3A strain F mutation S443P (in a re-
gion adjacent to HRB) has a hyperactive fusion phenotype
(Paterson et al., 2000). The mechanisms by which these mu-
tations lower the energy required to activate metastable F
and their effects on F protein intermediates and fusogenic F
are unclear.
High resolution structures have been determined for
6HBs formed by peptides derived from the HRA and HRB
regions of the paramyxovirus F proteins from SV5 and
HRSV F (Baker et al., 1999; Zhao et al., 2000). For SV5,
the 6HB was formed by peptide N-1 containing all of HRA
and part of the fusion peptide, and by peptide C-1 contain-
ing all of HRB and an extended chain region (Fig. 1). The
Figure 1.  Schematic diagram of the 
paramyxovirus fusion (F) protein. The 
positions of the fusion peptide (FP), 
HRA (residues 129–184),  -barrel do-
main ( -barrel), Ig-like domain (Ig-like), 
HRB (residues 449–477), and TM are 
shown. The locations of the N-1 and
C-1 peptides from SV5 F and the inter-
pretable structure of NDV F are indi-
cated. The asterisks denote SV5 residues 
P22 and P443, and the NDV mutant 
L289A, which have been implicated 
previously in HN-independent fusion 
(Ito et al., 2000; Paterson et al., 2000; 
Sergel et al., 2000). (B) Sequence align-
ment of the N-1 and C-1 peptides de-
rived from SV5 F with the correspond-
ing residues of F proteins from other 
paramyxovirus genera. HRSV, human 
respiratory syncytial virus. The asterisks 
denote the SV5 N-1 cavity residues, the 
C-1 cavity-binding residues L447 and 
I449, and residue 443, which has a hy-
peractive fusion phenotype when mu-
tated to a proline residue. (C) High res-
olution structure of the SV5 6HB (Baker 
et al., 1999). The core N-1 trimer is de-
picted in a surface representation col-
ored by surface curvature, and the anti-
parallel C-1 monomers are depicted by 
worm representations (magenta). (D) 
The packing of L447 and I449 into the 
hydrophobic N-1 cavity. Three N-1 
(green) chains and one C-1 (magenta) 
chain are depicted by worm representa-
tions. (E) Worm representation of one 
monomer of the high resolution struc-
ture of NDV F. Arrows indicate posi-
tions of the SV5 and NDV residues im-
plicated in HN-independent fusion 
(SV5 22 and 443 and NDV 289). The 
expected COOH-terminal continuation of the chain trace in the fusogenic/postfusion structure is depicted by the black dotted line to show 
where SV5 F residues 443, 447, and 449 are expected to be located. The structures in both C and E have the same orientations, with the 
NH2 termini of HRA at the bottoms of both panels.T
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trimer-of-heterodimer structures of these complexes share a
remarkable similarity to those of other type I vFGps (Skehel
and Wiley, 2000; Eckert and Kim, 2001), including promi-
nent cavities in the HRA cores to which residues adjacent to
HRB such as SV5 F L447 and I449 pack tightly (Fig. 1). As
predicted by the continuation of the HRA coiled coil into
the fusion peptide and the proximity of the HRB helices to
the TM domain (Baker et al., 1999), experiments on the ar-
rest and capture of SV5 F intermediates are consistent with
the formation of the 6HB being coupled directly to mem-
brane merger (Russell et al., 2001). The atomic structure of
NDV F has been determined from a crystal consisting of a
mixture of uncleaved F
 
0
 
 and cleaved F (cleaved at residue
139 in the fusion peptide region instead of the biological
cleavage site at 117; Chen et al., 2001). Unfortunately, there
is a lack of interpretable electron density for axial crystal
contacts and for the fusion peptide, NH
 
2
 
-terminal half of
HRA, and HRB regions. Therefore, the roles of the HR re-
gions in the structural transitions of F during the fusion pro-
cess remain unclear (Colman and Lawrence, 2003).
To understand the role of the cavity-binding residues in
6HB formation and F-mediated fusion, we mutated SV5 F
residues L447 and I449 adjacent to HRB in SV5 F. Muta-
tion of the HRA cavity-binding residues destabilizes the
6HB structure and decreases the inhibitory potency of SV5
C-peptides in a correlative manner. These results identify in
the F protein the physical target of the potent C-1 inhibitory
peptide. Unexpectedly, the effects of the L447 and I449 mu-
tations on F protein activation were even more drastic than
their effects on 6HB formation. Residues 447 and 449 are
shown here to be critical determinants of the energetic
threshold required for activation of metastable F. In fact,
mutant F proteins containing aromatic mutations at L447
and I449 cause hyperactive fusion despite having reduced
6HB stabilities, thus displaying a novel phenotype in which
6HB stability does not correlate with fusogenicity. Com-
bined with previous data from this paper showing that resi-
due 443 is also critical in the activation of F, the present data
show that the residues comprising a linear segment adjacent
to HRB (including [but not limited to] residues 443, 447,
and 449) regulate the stabilization and controlled activation
of metastable F. Overall, the data are consistent with this
linear segment having dual interaction sites in F, one in
metastable F and one in the 6HB, thereby providing a key
regulation of the precise switch between the metastable and
fusion-active forms of the protein. We propose that other
type I vFGps like HIV gp41 may have evolved similar dual-
functional residues to control the precise switch between
their native and fusogenic structures.
 
Results
 
Cavity-binding residues in C-1 stabilize the 6HB
 
In the 6HB structure, C-1 residues L477 and I449 pack into
a prominent cavity formed by conserved N-1 residues (Fig.
1). To study the role of these residues in stabilizing the
6HB, we performed an experiment analogous to a study on
HIV-1 gp41-derived peptides (Chan et al., 1998). C-1 pep-
tides containing mutations at L447 and I449 of varying hy-
drophobic bulk (Gly, Ala, Val, Ile/Leu, Phe, and Trp) were
incubated with N-1. Similar to the wild-type (wt) 6HB
complex, all of the mutant peptide complexes formed trim-
ers of heterodimers with high 
 
 
 
-helical content, as deter-
mined by analytical ultracentrifugation and circular dichro-
ism (Table I). Analysis of the thermal melts of the 6HB
complexes showed that the mutations resulted in 6HB sta-
bilities with the following rank order: Gly 
 
 
 
 Ala 
 
 
 
 Trp 
 
 
 
Phe 
 
 
 
 Val 
 
 
 
 Ile/Leu 
 
 
 
 wt (Table I; Fig. 2, A and B). For
the mutants containing aliphatic residues, 6HB stability cor-
related with hydrophobic bulk (Gly 
 
 
 
 Ala 
 
 
 
 Val 
 
 
 
 wt) and
conservation of packing interactions (Ile/Leu 
 
 
 
 wt). The de-
crease in 6HB stability due to an increase in aromatic
 
Table I. 
 
C-1 mutant peptides: 6HB stability and fusion inhibition
M
 
obs
 
/M
 
calc
a
 
[
 
 
 
]
 
222
b
 
T
 
m
b,c
 
T
 
m
 
 in 2 M GuHCl
 
b,d
 
IC
 
50
 
 inhibition
 
e
 
 
 
C
 
 
 
Cn M
 
W3A wt 2.9
 
 
 
30 167
 
 
 
98 88 38 
 
 
 
 4
L447G 2.7
 
 
 
28 922 86 72 150 
 
 
 
 19
L447A 2.8
 
 
 
29 328 88 78 92 
 
 
 
 10
L447V 2.8
 
 
 
29 495 91 81 83 
 
 
 
 11
L447I 2.8
 
 
 
29 820 94 83 50 
 
 
 
 7
L447F 2.9
 
 
 
29 407 90 79 100 
 
 
 
 12
L447W 3.1
 
 
 
29 381 89 79 106 
 
 
 
 8
I449G 2.9
 
 
 
25 390 79 67 271 
 
 
 
 24
I449A 2.8
 
 
 
27 384 87 74 115 
 
 
 
 7
I449V 3.0
 
 
 
28 847 96 85 58 
 
 
 
 6
I449L 2.8
 
 
 
29 291 97 87 54 
 
 
 
 5
I449F 2.9
 
 
 
27 408 87 74 151 
 
 
 
 12
I449W 2.9
 
 
 
27 362 85 73 146 
 
 
 
 13
 
a
 
Sedimentation equilibrium data for N-1/C-1 complexes are reported as the ratio of the experimentally determined mol wt to the calculated mol wt for an
N-1/C-1 heterodimer.
 
b
 
Circular dichroism data for 10 
 
 
 
M each of N-1 and C-1 peptides in PBS, pH 7.0 (units 
 
 
 
 deg cm
 
2
 
 dmol
 
 
 
1
 
).
 
c
 
The midpoint of thermal denaturation (T
 
m
 
) was estimated from the maximum of the first derivative of [
 
 
 
]
 
222
 
 plotted as a function of temperature.
 
d
 
Thermal melts in the presence of 2.0 M GuHCl.
 
e
 
C-1 mutant peptide IC
 
50
 
 values for inhibition of cell–cell fusion using the T7 luciferase reporter gene assay.T
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sidechain bulk is also consistent with the conservation of
packing interactions stabilizing the 6HB. Together, the data
indicate that specific hydrophobic contacts between L447
and I449 and N-1 stabilize the SV5 F 6HB. However, the
C-peptide with the most destabilizing mutation studied
here, I449G, still contributed to the formation of a 6HB
with a T
 
m
 
 of 79
 
 
 
C (only 
 
 
 
20
 
 
 
C lower than the wt 6HB).
 
C-peptide inhibitory potency is directly proportional 
to 6HB stability
 
To examine the relationship between the abilities of mu-
tant C-peptides to stabilize the 6HB and their abilities to
inhibit membrane fusion, we determined the IC
 
50
 
 values of
the C-peptides and compared them to their corresponding
6HB T
 
m
 
 values. The L447 and I449 sidechains contribute
to C-1 inhibitory potency with the rank order of IC
 
50
 
 value
varying by guest residue as follows: Gly 
 
 
 
 Trp 
 
  
 
Phe 
 
 
 
Ala 
 
 
 
 Val 
 
 
 
 Ile/Leu 
 
 
 
 wt (Table I; Fig. 2, C and D).
However, the C-peptide with the lowest inhibitory po-
tency studied here, I449G, still had an IC
 
50
 
 value only ap-
proximately sevenfold higher than the wt C-1 peptide. The
C-peptide IC
 
50
 
 values correlate with their corresponding
6HB thermal stabilities (Fig. 2 F). The apparent linear re-
lationship between log IC
 
50
 
 and T
 
m
 
 indicates C-peptide in-
hibitory potency is directly related to C-peptide affinity for
the N-1 core. The data are consistent with C-1 binding to
a triple-stranded coiled-coil conformation of HRA and in-
hibiting membrane fusion by preventing the formation of
the 6HB by the F protein.
 
Most of the L447 and I449 mutations are tolerated 
in the full-length protein
 
We constructed the L447 and I449 mutants in the back-
ground of the F protein and expressed these F protein mu-
tants using both the pGEM-VacT7 and pCAGGS expres-
sion systems (see Materials and methods). The expression
levels of individual F mutants did not vary between the two
expression systems (Table II). The percentage of cells trans-
fected did not differ significantly between wt and mutant F
proteins (unpublished data); however, the mean fluores-
cence intensity values of transfected cells varied significantly
(Table II). The L447F and I449G mutations caused a large
reduction in F protein cell surface expression levels relative
to wt, perhaps due to misfolding or a transport defect. The F
protein aromatic mutants L447W, I449F, and I449W had
cell surface expression levels between 50 and 75% of wt. The
F protein aliphatic mutants L447G, I449A, and I449L had
expression levels of 65–85% wt, and L447A, L447V, and
L447I had expression levels similar to wt. Variable cell sur-
face expression levels of the mutants requires quantitative
membrane fusion assays to control for differential cell sur-
face expression.
Figure 2. Biophysical data on SV5 
6HBs formed by N-1 and C-1 L447 and 
I449 mutants. (A) Thermal melts of L447 
6HBs monitored by circular dichroism at 
222 nm at 10  M concentration each of 
N-1 and C-1 in 2 M GuHCl (PBS buffer, 
pH 7.0). (B) Thermal melts of I449 6HBs 
(same conditions as A). (C) Peptide inhi-
bition dose–response curves measured 
by the luciferase assay for the L447
C-peptide mutants. Error bars repre-
sent triplicate experiments. (D) Dose–
response curves for the I449 C-peptide 
mutants. Conditions identical to C. (E) 
Representative analytical ultracentrifu-
gation data (20,000 rpm) for I449F at 
20 C in PBS (pH 7.0) at 10  M concen-
tration each of N-1 and C-1. A fit of the 
data to a single-ideal species model re-
sults in an observed mass of 32,470 D 
(calculated mass is 33,225 D) and no 
systematic deviation in residuals. (F) 
Correlation of C-1 inhibitory potency 
and N-1/C-1 6HB stability. C-1 peptide 
mutants at L447 and I449 were tested for 
inhibition of cell–cell fusion by the T7 
luciferase reporter gene assay. The log 
IC50 values are plotted against the Tm of 
the corresponding N-1/C-1 complex. 
The Tm of the wt 6HB was estimated as 
100 C. Error bars represent triplicate ex-
periments.T
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The F proteins containing aromatic mutations exhibit 
an altered conformation associated with hyperactive 
fusion activity
 
The F protein of SV5 WR strain requires HN coexpression
to mediate fusion under physiological conditions (Ito et al.,
2000). In contrast, the F protein of SV5 W3A strain medi-
ates fusion in the absence of HN, albeit to a reduced extent
when compared with HN coexpression (Paterson et al.,
1985). Although the amino acid sequences of the two strains
differ at residues 22, 443, and 516, previous work has shown
that proline residues at positions 22 and 443 enhance mem-
brane fusion and contribute to HN-independent fusion (Ito
et al., 2000; Paterson et al., 2000). The WR and W3A strain
F proteins have at position 22 the residues Leu and Pro, re-
spectively, and have at position 443 the residues Pro and
Ser, respectively. The conformation-specific mAb 21-1 is
highly reactive to the fusion-hyperactive WR F mutant
L22P, but shows little reactivity to the HN-dependent
WR F unless WR F is heated to 47
 
 
 
C (Tsurudome et al.,
2001). Although the epitope for mAb 21-1 has been
mapped to the NH
 
2
 
-terminal half of F
 
2
 
 and the 
 
 
 
-sheet
domain in F1 (Tsurudome et al., 2001), the fusion-hyper-
active SV5 W3A F mutant S443P (residue 443 is not in
the mAb 21-1 epitope) also has increased mAb 21-1 reac-
tivity (Table II). Thus, mAb 21-1 can be used as a sensi-
tive probe for F protein conformational changes related to
heightened fusion activation. Flow-cytometric analysis of
mAb 21-1 reactivity to the W3A strain F mutants at L447
and I449 in the absence of HN coexpression showed that
F proteins containing the aliphatic mutations maintain
wt-like reactivity, whereas F proteins containing the aro-
matic mutations have increased reactivity (Table II). The
results are consistent with the following W3A F mutations
resulting in partial triggering of F in the absence of HN
coexpression or target binding: S443P, L447F, L447W,
I449F, and I449W.
 
The F mutants show variable dependence on HN 
for fusion activation
 
To examine the abilities of the mutant F proteins to cause
cell–cell fusion, syncytium formation was examined. Rep-
resentative photomicrographs of syncytium formation in
BHK cells transfected with the F mutants are shown in Fig.
3 A. All of the mutants except I449G (which has a cell sur-
face expression level 
 
 
 
10% of wt) promoted syncytium for-
mation when coexpressed with SV5 HN (Table III). In the
presence of HN coexpression, I449A and I449V promoted
syncytium formation less efficiently than wt F, whereas the
remainder of the F proteins containing aliphatic mutations
promoted syncytium formation similar to wt F. When coex-
pressed with HN, the F proteins containing aromatic muta-
tions promoted larger syncytium formation than wt F (Fig.
3 A). Therefore, the effects of the L447 and I449 mutations
on syncytium formation do not correlate with their effects
on 6HB stability.
In the absence of HN coexpression, L447I and I449L
were the only F proteins with aliphatic mutations that pro-
moted syncytium formation, although to a reduced extent
than wt F. In contrast, the F proteins with aromatic muta-
tions promoted larger syncytium formation than wt in both
the presence and absence of HN coexpression. The F pro-
teins containing aromatic mutations appear to have a less
stringent requirement for HN coexpression for F-mediated
syncytium formation, whereas the F proteins containing ali-
phatic mutations are more dependent on HN coexpression.
Again, the effects of the mutations on syncytium formation
in the absence of HN coexpression do not correlate with
their effects on 6HB stability.
To quantify the fusion phenotypes of the mutants, we
used a luciferase gene-reporter assay to measure content mix-
ing. As the extent of fusion mediated by SV5 F is dependent
on cell surface expression levels and the expression levels of
the mutants varied, we first measured the luciferase activities
 
Table II. 
 
L447 and I449 mutant F protein expression and mAb 21-1 reactivity
F1 express
 
a
 
 
pGEM
 
b
F1 express
a 
pCAGGS
c
Surface express
d 
pGEM
b
Surface express
d 
pCAGGS
c
21-1 reactivity
e 
pGEM
b
21-1 reactivity
e 
pCAGGS
c
SV5 F wt
f 100 100 100 100 100 100
L447G 61.5 70.6 85.0 61.7 77.9 56.9
L447A 103.9 120.1 107.9 92.8 86.7 75.7
L447V 114.4 96.8 107.1 99.2 82.4 73.7
L447I 113.0 90.6 103.9 110.1 99.5 99.1
L447F 15.8 9.6 10.3 15.3 135.0 104.5
L447W 65.0 75.8 51.8 79.6 194.1 123.6
I449G 22.2 19.6 9.7 8.1 4.0 30.8
I449A 46.5 49.6 72.0 63.1 76.3 74.4
I449V 117.1 119.7 97.9 92.3 86.1 79.3
I449L 86.7 105.0 83.1 86.8 81.2 69.4
I449F 53.3 57.1 68.6 55.7 129.8 123.4
I449W 48.8 61.7 42.3 57.0 156.2 127.9
S443P 96.4 98.2 91.6 102.0 167.5 160.5
aTotal F1 expression after a 15-min 
35S-Met pulse labeling and a 3-h chase.
bpGEM2X DNA transfected into CV-1 cells, vaccinia vTF7-3 coinfection.
cpCAGGS DNA transfected into Vero cells.
dCell surface expression measured by flow cytometry using the mAb F1A.
eReactivity of cell surface–expressed F mutants to the conformation-specific mAb 21-1, as determined by flow cytometry.
fAll values were normalized to SV5 wt F protein.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
368 The Journal of Cell Biology | Volume 163, Number 2, 2003
resulting from various amounts of wt F cell surface expres-
sion, as indicated by the lines connecting the open squares in
Fig. 3 (B and C). The fusion activity of wt F as a function of
expression in the presence and absence of HN coexpression
is reported in Fig. 3 (B and C, respectively). In the presence
of HN coexpression, the F proteins containing aliphatic mu-
tations had fusion activities similar to wt when compared
with equivalent expression levels (Fig. 3 B). However, F pro-
teins containing aliphatic mutations were much less efficient
than wt in causing fusion in the absence of HN coexpression
(Fig. 3 C). In contrast, the F proteins containing aromatic
mutations had fusion-hyperactive phenotypes both in the
presence and absence of HN coexpression (Fig. 3, B and C;
points above the lines). These results are consistent with the
syncytia and mAb 21-1–binding analyses (Table II).
The F mutants are not blocked in a prehairpin 
conformation or in a form that only causes hemifusion
The L447 and I449 mutations in C-1 reduce 6HB stability
(Table I; Fig. 2), and the available data indicate that 6HB
formation is coupled directly to membrane merger (Russell
et al., 2001). In principle, the reduction in fusion activity by
the F proteins containing aliphatic mutations could be due
to a decrease in energy released per 6HB given a fixed num-
ber of activated trimers. If this were the case, fusion might
be arrested at either a hemifusion stage (characterized by the
ability to promote lipid but not content mixing; Melikyan et
al., 1999; Armstrong et al., 2000) or after formation of a tar-
get membrane–inserted prehairpin intermediate (character-
ized by the ability to retain bound RBCs independent of
HN; Russell et al., 2001). To test the effects of the muta-
tions on late steps in fusion, we performed a dye transfer as-
say for fusion using dual-labeled (lipidic R18 and aqueous
carboxyfluorescein [CF]) RBCs. There were no significant
differences between the extents of transfer of R18 lipidic dye
and CF aqueous dye for any individual mutant, whether co-
expressed with SV5 HN or when coexpressed with un-
cleaved influenza virus HA (fusion inactive) as a binding
protein (Table III). Therefore, the mutants do not exhibit a
hemifusion phenotype. Consistent with the results obtained
from syncytia analysis and from the luciferase assay, the F
proteins containing aliphatic mutations had a great reduc-
tion in dye transfer in the absence of HN coexpression.
Unexpectedly, we found the F proteins containing aro-
matic mutations L447F and L447W did not promote dye
transfer, and that I449F and I449W promoted dye transfer
inefficiently. To address the apparent anomaly of these mu-
tants having a fusion-hyperactive phenotype in syncytium
formation and the luciferase assay, but a fusion-deficient
phenotype in the dye transfer assay, we performed the dye-
transfer assay using CF-labeled RBC target cells and SYTO-
17–labeled CV-1 effector cells. With the modified assay,
both syncytium formation by CV-1 effector cells and dye
transfer from RBC target cells were visualized simulta-
neously. Moreover, the differential labeling of CV-1 cells
and RBCs also allows for analysis of F-dependent retention
of target RBCs resulting from a prehairpin conformation of
the F protein that is likely anchored to both cell membranes
through the TM and fusion peptide regions (Russell et al.,
2001). Incubation of the effector–target cell complexes at
Figure 3. Cell–cell fusion assays. (A) Representative photomicro-
graphs of syncytia formed between BHK cells expressing the F mu-
tants in the presence and absence of HN coexpression (20 h after 
transfection). Arrows point to syncytia. Bar, 200  m. (B and C) Cell–
cell fusion monitored by the luciferase reporter gene assay in the 
presence (B) and absence (C) of HN coexpression. The data in both 
panels are normalized to 100% fusion corresponding to the lu-
ciferase activity resulting from coexpression of HN and F (2  g F 
DNA). F protein expression levels were determined by flow cytome-
try using the mAb F1a. Open boxes correspond to titrating increas-
ing amounts of wt F DNA. Closed circles correspond to transfection 
of 2  g F mutant DNA. Error bars represent triplicate experiments.T
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37 C resulted either in dye transfer or the release of unfused
RBCs (due to a decrease in affinity of HN for its receptor
sialic acid upon heating at 37 C; Corey et al., 2003; Fig. 4).
The lack of F-dependent RBC retention by mutants with in-
efficient dye transfer is consistent with the mutations affect-
ing an F protein intermediate preceding prehairpin for-
mation (Russell et al., 2001), and not due to differential
binding of RBCs because all of the mutant F proteins bound
similar numbers of RBCs (unpublished data). Differential
levels of syncytium formation occurred between CV-1 cells
expressing HN and the F mutants before incubation of ef-
fector–target cell complexes at 37 C (unpublished data), as
can be seen in the images collected after 37 C incubation
(Fig. 4). The large syncytia formed between cells coexpress-
ing HN and the F proteins containing aromatic mutations
(Fig. 4, arrows) indicates these mutations cause the F pro-
Table III. Membrane fusion efficiencies of L447 and I449 mutant F proteins
Syncytia
a Syncytia
a R18 dye
d CF dye
e R18 dye
d CF dye
e
 HN
b  HN
c  HN
f  HN
f  HN
g  HN
g
SV5 F wt
f       105   10 107   13 34   4 34   5
L447G      65   5 66   61    11    1
L447A      82   7 80   60    10    1
L447V      83   13 83   10 3   13    1
L447I      97   9 94   9 16   3 17   3
L447F         0   00    00    00    0
L447W         0   00    00    00    0
I449G    0   00    00    00    0
I449A    85   6 84   71    11    1
I449V    89   8 88   72    12    1
I449L      67   6 65   42    11    1
I449F         12   3 11   35    25    2
I449W         18   2 18   33    13    2
S443P         168   7 166   6 139   8 138   8
aSyncytia assays performed 20 h after transfection on monolayers of BHK 21F cells. The extents of syncytia formation were ranked as follows:    , notice-
ably greater than wt;   , similar to wt;  , noticeably less than wt;  , no syncytia formation.
bF protein coexpressed with SV5 HN.
cAssay performed in the absence of HN transfection.
dAverage number of R18 lipid dye transfer events per microscopic field from target RBCs to effector CV-1 cells expressing F mutants.
eAverage number of CF aqueous dye transfer events per microscopic field from target RBCs to effector CV-1 cells expressing F mutants.
fF protein coexpressed with SV5 HN.
gF protein coexpressed with uncleaved influenza virus HA as an RBC-binding protein.
Figure 4. Cell–cell fusion monitored by dye transfer. Target cell 
erythrocytes (RBCs) were labeled with the green fluorescent dye
6-CF, and effector CV-1 cells coexpressing SV5 F mutants and HN 
were labeled with the red fluorescent dye SYTO-17. Effector CV-1 
cells were infected with vaccinia virus vTF7-3 and transfected with 
F and HN DNA for 4 h at 37 C, incubated for 18 h at 33 C, labeled 
with SYTO-17 for 1 h at 37 C, coincubated with CF-labeled RBCs 
for 1 h at 4 C, incubated for 15 min at 37 C, and incubated on ice 
before confocal microscopic visualization. Membrane fusion is ob-
served as transfer of green CF from the small RBCs to the large red-
labeled CV-1 effector cells, resulting in a yellow appearance in the 
merge image. Large syncytium formation before 37 C incubation of 
effector–target cell complexes but low dye transfer by I449F and 
I449W or no dye transfer by L447F and L447W (denoted by arrows) 
is consistent with significant inactivation of the aromatic mutants by 
the time the complexes were incubated at 37 C. Incubation of RBC/
CV-1 cell complexes for 15 min at 37 C resulted in a loss of RBC 
binding, consistent with the fusion deficiencies of the F proteins 
containing aliphatic mutations arising in an F protein intermediate 
preceding the prehairpin intermediate. The prehairpin intermediate 
retains bound RBCs during C-1 inhibition presumably due to inser-
tion of the fusion peptide into the target membrane. Images are 
cropped one-quarter field views. Bar, 200  m.T
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teins to exhibit a hyperactive fusion–promotion ability after
reaching the cell surface, provided target cells are proximal.
However, the lack of efficient dye transfer after 18 h incuba-
tion at 33 C before target RBC coincubation for 1 h at 4 C
and 15 min incubation at 37 C is completely consistent
with these F proteins containing aromatic mutations becom-
ing inactivated in the absence of fusion targets. It should be
noted that for the luciferase assay, the transiently transfected
Vero cells were incubated for 18 h at 37 C before target T7-
BSR cell coincubation for 8 h at 37 C, so that the combina-
tion of a long coincubation time (8 h vs. 15 min) and con-
tinuous (further) expression of the F protein mutants did
not reveal the “do-or-die” phenotype of the F proteins con-
taining aromatic mutations that was observed in the RBC
dye-transfer assay. Additionally, Vero cells were specifically
chosen for the luciferase assay because Vero cells do not
form syncytia after 18 h of transient transfection with the F
protein mutants, whereas transiently transfected BHK cells
and infected/transfected CV1 cells do form syncytia 18 h af-
ter transfection. The fusion-hyperactive S443P mutant did
not become inactivated under the conditions of the RBC
dye-transfer assay (Table III), suggesting that the hyperactive
fusion phenotype of the aromatic mutations at L447 and
I449 differs from that of S443P, despite both S443P and the
aromatic mutations at L447 and I449 having increased reac-
tivity to mAb 21-1, increased syncytium formation, and in-
creased luciferase activity.
The L447 and I449 mutations change the level 
of the F protein activation barrier
Previous experiments on the temperature dependence of fu-
sion by WR strain F, W3A strain F, and the W3A mutants
S443P and P22L are consistent with the F protein being acti-
vated from a metastable state, as these experiments showed
that F protein residues 22 and 443 modulate fusion activity
by altering the energetic threshold for fusion activation
(Paterson et al., 2000). To test whether the L447 and I449
W3A strain F mutants had altered fusion efficiencies due to
altered activation thresholds, we studied the temperature de-
pendence of their dye-transfer efficiencies (Fig. 5 A). Consis-
tent with the F proteins containing aliphatic mutations hav-
ing larger activation thresholds than wt F, these mutant F
proteins caused increasing extents of fusion at increasing in-
cubation temperatures. In contrast, the two F proteins con-
taining aromatic mutations that caused a limited amount of
dye transfer, I449F and I449W, reached their maximum (al-
beit low) fusion extents at or below 22 C (Fig. 5 A), pro-
moted dye transfer at a slower initial rate than wt, and
reached their final extents of fusion faster than wt (Fig. 5 B).
Thus, dye transfer by F proteins I449F and I449W either oc-
curs rapidly without a high thermal requirement or not at all.
In the RBC dye-transfer assays, although the F proteins
containing aromatic mutations caused massive syncytium
formation between CV1 cells (Fig. 4, arrows), they caused
little or no dye transfer, but when observed, it occurred at
low temperature (Fig. 5 B). Therefore, we hypothesized that
the aromatic mutations were not only destabilizing the F
protein upon surface expression (thereby enhancing syncytia
formation), but were also inactivating the F protein rela-
tively quickly (thereby diminishing dye transfer from RBC
target cells coincubated with CV-1 effector cells hours after
cell surface expression of the F mutants). To prevent the sus-
pected inactivation of the F proteins containing aromatic
mutations in the absence of CF-labeled RBC target cells, we
introduced these mutations into the background of a mu-
tant (FR3) that only contains three Arg residues in the F
protein cleavage/activation site, and thus is not cleaved by
furin, but can be cleaved by addition of exogenous trypsin
(Ward et al., 1995). Cleavage of the double mutants (FR3
mutants containing aromatic substitutions at 447 and 449)
at 4 C followed by coincubation with CF-labeled RBCs at
4 C and a warm-up to 22 or 37 C resulted in extremely effi-
Figure 5. Cell–cell fusion measured by CF dye transfer from tar-
get RBCs to effector CV-1 cells coexpressing SV5 HN and F pro-
teins containing mutations at L447 and I449. Conditions of the as-
say were similar to those detailed in Fig. 4, except either the 
incubation temperature (A) or incubation time (B) were varied to 
probe fusion kinetics. Averages and error bars are from statistical 
analyses of 3–5 microscopic fields. (A) Temperature dependence of 
fusion measured by CF dye transfer. Effector–target cell complexes 
were incubated at various temperatures for 5 min. No dye transfer 
was observed after incubation at any of the reported temperatures 
for no F DNA transfected or for the mutants L447F, L447W, and 
I449G. The F proteins containing the aliphatic mutations have in-
creasing fusion extents as the incubation temperature is increased, 
whereas the F proteins containing the aromatic mutations I449F and 
I449W reach maximal fusion extents at a temperature as low as 
22 C. (B) Kinetics of CF dye transfer for wt and the aromatic mutants 
at L447 and I449. In the presence of HN coexpression, wt F reached 
a maximal fusion extent within 5 min and F I449F and F I449W 
reached a maximum within 2.5 min. Cotransfection of uncleaved 
influenza virus Udorn HA (fusion inactive) in addition to SV5 F and 
HN led to retention of target RBCs after 15 min, but did not lead to 
an increase in the extent of dye transfer (not depicted).T
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cient dye transfer (Fig. 6). In contrast, the pseudo wt FR3
mutant (with only the 2-residue deletion in the cleavage site)
did not cause dye transfer after incubation at 22 C, but in-
stead required heating to 37 C for efficient dye transfer. The
data show that the F proteins with aromatic mutations at
residues 447 and 449 are hyperactive for dye transfer when
they are incorporated into the FR3 protein, and are thus
prevented from premature inactivation in the absence of tar-
get cells.
Discussion
Biochemical analyses are consistent with the paramyxovirus
F protein adopting the following conformations during
membrane fusion: (1) the native metastable structure; (2) an
activated intermediate that is susceptible to N-peptide bind-
ing; (3) a prehairpin intermediate that is susceptible to C-pep-
tide binding; and (4) a fusogenic or post-fusogenic form that
has as its core a 6HB formed by HRA and HRB (Fig. 7 A;
for review see Russell et al., 2001). The importance of the
HR regions in the paramyxovirus fusion mechanism is sug-
gested by their conservation (Fig. 1) and their requirement
for fusion activity (Buckland et al., 1992; McGinnes et al.,
2001; Sergel et al., 2001). Additionally, peptides derived
from the HR regions of paramyxovirus F inhibit fusion (for
review see Colman and Lawrence, 2003), presumably by
preventing 6HB formation, which appears to be coupled di-
rectly to membrane fusion (Russell et al., 2001). Here, we
define a relatively localized segment upstream of HRB (resi-
dues 443, 447, and 449) in the F polypeptide chain that
provides a key regulatory switch between the native and fu-
sogenic conformations of the F protein. First, residues 447
and 449 engage a hydrophobic pocket of the HRA coiled
coil in the fusogenic 6HB conformation, with mutations of
these residues affecting the overall stability of the final 6HB
conformation. Second, the correlated patterns of 6HB sta-
bility and C-peptide inhibition of F-mediated fusion con-
firm that the HRA coiled coil is the physical target of the
C-peptide in the intact F protein. Third, and most impor-
tantly, residues 443, 447, and 449 profoundly influence the
activation barrier of the metastable, prefusion F conforma-
tion in a manner that is not anticipated from analysis of the
6HB structure (Fig. 7 B). Therefore, residues 443, 447, and
449 must play two distinct structural and functional roles in
the prefusion and 6HB conformations.
Electron microscopic analyses show that HRSV F adopts
cone- and lollipop-shaped morphologies that both have
“head-out” orientations in rosettes (Calder et al., 2000).
The cone-shaped form most likely represents a prefusogenic
F, whereas the lollipop-shaped form most likely represents
fusogenic F with its 100-Å long rodlike stalk corresponding
to a 6HB formed by the HR regions. The crystal structure
of NDV F is thought to correspond to common structures
shared by both the native and fusogenic forms of F (Chen
et al., 2001). However, the lack of interpretable electron
density for the fusion peptide, HRB, and the NH2-terminal
half of HRA suggests these regions adopt different struc-
tures in both forms. In the fusogenic or post-fusogenic
structure, HRB and residues 447 and 449 bind in the
grooves of the HRA coiled coil, forming a 6HB revealed in
the structure of the SV5 core complex (Baker et al., 1999).
In the native prefusion structure, we suggest that the resi-
dues adjacent to HRB (SV5 F residues 443, 447, and 449)
make alternative contacts within F because they are key reg-
ulators of the stabilization and activation of native F, even
in the absence of HN. The binding of these and potentially
other residues in HRB within the native structure may con-
tribute to its cone-shaped morphology (in comparison with
the lollipop-shaped morphology; Calder et al., 2000). The
data also suggest that the transition from the native to the
fusogenic forms of F must include the formation of a
prehairpin intermediate containing a triple-stranded HRA
coiled coil, which is accessible for C-peptide binding, but
not for HRB binding (Fig. 7 A). Conserved packing inter-
actions between the cavity-binding residues 447 and 449
and the HRA hydrophobic cavity are critical in stabilizing
Figure 6. The F proteins containing aromatic mutations cause 
efficient dye transfer. Cell–cell fusion measured by CF dye transfer 
from target RBCs to effector CV-1 cells coexpressing SV5 HN and 
FR3 (trypsin-inducible cleavage mutation of 5 Arg to 3 Arg residues 
at the cleavage site) proteins containing aromatic mutations at L447 
and I449. CV-1 effector cells were incubated at 4 C for 1 h either in 
the presence ( T) or absence ( T) of 10  g/ml TPCK-trypsin, subse-
quently coincubated with target RBCs at 4 C for 1 h and then incu-
bated at either 22 or 37 C for 15 min. Trypsin-cleaved FR3 mutants 
with aromatic mutations at 447 and 449 efficiently cause CF dye 
transfer at both 22 and 37 C, whereas the pseudo wt FR3 mutant 
(with only the 5 Arg to 3 Arg mutation at the cleavage site) does not 
cause dye transfer at 22 C. Bar, 20  m.T
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the 6HB structure. All of the mutations of cavity-binding
residues studied here decrease 6HB stability. Moreover, the
paramyxovirus F proteins generally compensate for non-
identical residues in the HRA cavity with complementary
changes in HRB cavity–binding residues (Zhao et al.,
2000). The 6HB structures from filoviral, retroviral, and
lentiviral vFGps such as Ebola virus GP2, HIV gp41, SIV
gp41, MoMLV TM, HTVL-1 gp21, and Visna virus TM
also reveal prominent hydrophobic HRA cavities that may
be suitable drug targets (for review see Eckert and Kim,
2001). The importance of the cavity-binding residues in
both the native and fusogenic structures of paramyxovirus F
suggests that the evolution of drug-resistant strains against
such inhibitors would occur infrequently.
Unexpectedly, the effects of the mutations on fusion acti-
vation appear to be greater than their effects on 6HB forma-
tion. The F proteins containing aromatic mutations form
less stable 6HBs than wt F (Fig. 2), thereby coupling less en-
ergy to fusion per 6HB. The hyperactive phenotype of the F
proteins containing aromatic mutations is consistent with
these mutations destabilizing the F protein native metastable
state so that more trimers become activated (Fig. 7 B). In
contrast, it seems most likely that the F proteins containing
aliphatic mutations have both higher energetic requirements
for activation and lower amounts of energy per 6HB to cou-
ple to fusion (Fig. 7 B). For the F proteins containing the al-
iphatic mutations, the decrease in fusion activity is most
likely due to the combination of decreases in the number of
activated trimers and the amount of energy released per
6HB. The fusion deficiencies of the aliphatic mutants can-
not be due to their reduced 6HB stabilities alone because the
aliphatic mutants were restricted at fusion activation and not
at prehairpin or hemifusion intermediate formation.
To avoid inactivation, the native metastable structures of
the type I vFGps must prevent indiscriminate release of the
fusion peptide and HR regions until the target membranes
are within range. A general strategy for a tightly regulated fu-
sion mechanism may include sequences within or near HR
regions having dual structural roles; one in the native struc-
ture to regulate fusion activation and another in the final
structure to determine hairpin stability. The linear segment
from 443 to 449, adjacent to HRB, in the paramyxovirus F
protein has been shown here to be critical in stabilizing both
the native and fusogenic forms of the protein. Moreover,
mutational analyses on HIV gp41–mediated fusion have
identified individual HRA and HRB residues critical in the
stabilization of both the native gp120–gp41 complex and the
6HB structure (Lu et al., 2001; Follis et al., 2002; Sanders et
al., 2002). The strongest evidence for HR residues with dual,
independent interaction sites comes from structural and ge-
netic experiments on influenza virus HA. Numerous HRA
residues in HA2 (in segments A and C) bind to other HRA
residues in the native structure, but interact with the antipar-
allel buttressing strand (equivalent to a HRB region) in the
Figure 7. Model of the paramyxovirus fusion mechanism. (A) Previous reports have shown the paramyxovirus F protein adopts a series of 
conformations while mediating membrane fusion (for review see Russell et al., 2001); the native structure (which is in a metastable conforma-
tion), a temperature-arrested intermediate (which forms after HN binds its receptor at nonfusion-permissive temperatures and is susceptible to 
N-1 binding), a prehairpin intermediate (which adheres to target cells independent of HN and is susceptible to C-1 binding), and the fuso-
genic form of F (which couples 6HB formation to membrane merger). The present work is consistent with residues 447 and 449 having dis-
tinct interaction sites on the F protein, one in the native structure, and the other in the cavity formed by HRA trimers in the 6HB of the fuso-
genic form. The strong correlation between 6HB stability and C-peptide inhibitory potency in the present work and the coincidence of C-1 
inhibition and F protein binding in a previous work (Russell et al., 2001) show that C-1 inhibits membrane fusion by binding to transiently ex-
posed HRA triple-stranded coiled coils in the prehairpin intermediate. (B) Biophysical experiments on the N-1/C-peptide mutants show that 
the aliphatic (al) and aromatic (ar) mutations at L447 and I449 decrease the amount of energy released by mutant 6HB formation, whereas 
functional experiments on the F mutants are consistent with the aromatic (ar) mutations decreasing and the aliphatic (al) mutations increasing 
the activation energy of the native state. The hyperactive fusion phenotype of the aromatic mutants is consistent with the facile activation 
(and subsequent inactivation in the absence of a fusion target) of these F mutants overcompensating for the decrease in energy released by 
mutant 6HB formation.T
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fusogenic structure (Daniels et al., 1987; Bullough et al.,
1994; Chen et al., 1999). Other residues identified as critical
in the switch between the native and fusogenic structures
of HA2 include those in and around the fusion peptide
and those involved in interactions between HA2 and HA1
(Bullough et al., 1994), showing regions other than the HR
regions may be critical in stabilizing the native states of other
type I vFGps. Further structural and biochemical analyses on
the native metastable forms of these proteins will be instru-
mental in better understanding the general principles gov-
erning type I fusion activation and its inhibition.
Materials and methods
Peptides, cells, and plasmids
The N-1 (derived from HRA) and C-peptides (derived from HRB) were ex-
pressed and purified as described previously (Joshi et al., 1998). Mono-
layer cultures of Vero, BHK, T7-BSR, and CV-1 cells were grown as de-
scribed previously (Paterson et al., 2000). pGEM and pCAGGS plasmids
encoding SV5 W3A strain F, the SV5 FR3 mutant, SV5 HN, and influenza
virus A/Udorn/72 HA have been described previously (Paterson et al.,
2000). pGEX4T1 C-1 has been described previously (Joshi et al., 1998).
Mutant F proteins and C-peptides were constructed by subcloning four
primer PCR products into pGEM2X SV5 F, pGEM2X SV5 FR3, pCAGGS
SV5 F, and pGEX4T1 C-1.
Biophysical characterization of peptide 6HBs
Appropriate volumes of 6HBs were formed by mixing peptide stock solu-
tions to yield a final concentration of 10  M of each peptide in PBS (50
mM phosphate buffer, pH 7.0, and 150 mM NaCl) and dialyzing the mix-
tures twice against 4 l PBS. Sedimentation equilibria were measured at
20 C after a 24-h centrifugation at 15,000, 20,000 and 25,000 rpm using
an analytical ultracentrifuge (model XL-A; Beckman Coulter). The apparent
mol wts of the complexes were determined by fitting to a single-ideal spe-
cies model using Igor Pro (Wavemetrics). Circular dichroism experiments
on 6HB solutions (10  M of each peptide in PBS) were performed using a
spectropolarimeter (model J-715; Jasco) as described previously (Joshi et
al., 1998).
Expression of viral envelope glycoproteins
Viral envelope glycoproteins were expressed using two different expres-
sion systems: (a) Vero or BHK cells transfected with pCAGGS DNA and (b)
CV-1 cells infected with the recombinant vaccinia virus vTF7-3 and trans-
fected with pGEM DNA. Vero and BHK cells were transfected using the Li-
pofectAMINE™ Plus expression system according to the manufacturer’s in-
structions (Invitrogen). Transfected Vero and BHK cells were incubated for
4 h at 37 C before adding DME containing 10% FBS and incubating 18 h
at 37 C. CV-1 cells were infected with vTF7-3 and transfected with pGEM
DNA as described previously (Paterson et al., 2000). Transfected CV-1
cells were incubated for 4 h at 37 C before adding DME containing 10%
FBS and incubating for 18 h at 33 C. Metabolic labeling was performed as
described previously (Paterson and Lamb, 1993) with a 15-min pulse la-
beling (
35S-Promix, 50  Ci/well; Amersham Biosciences) and a 3-h chase.
Immunoprecipitations were performed using an antibody specific for F2.
Quantification was done using a bioimage analyzer (BAS1000; Fuji). Flow
cytometric experiments were performed as described previously (Paterson
et al., 2000) using mAb F1a at a 1:200 dilution (Paterson et al., 2000) or
mAb 21-1 at a 1:100 dilution (Tsurudome et al., 2001).
Syncytium formation
Monolayers of BHK 21F cells were transfected with F DNA alone or with F
and HN DNA as described above. Syncytia were photographed 20 h after
transfection with a digital camera (DCS 760; Kodak) attached to an in-
verted phase-contrast microscope (Diaphot; Nikon).
Luciferase reporter gene assay for content mixing
Vero cells were transfected with Luciferase Control DNA (Promega),
pCAGGS SV5 F, and pCAGGS HN (or HA) as described above. 18 h after
transfection, BSR cells (expressing T7 RNA polymerase) were removed
from T75 flasks and overlaid onto the Vero cells. After a 6-h incubation at
37 C, the monolayers were washed twice with PBS , overlaid with 100  l
Reporter Lysis Buffer (Promega), lysed by freeze-thawing, and clarified by
centrifugation at 14,000 rpm in an Eppendorf microcentrifuge. From each
clarified lysate, 40  l solution was pipetted into a 96-well plate. The lu-
ciferase activity resulting from fusion of the two-cell populations was
quantified using Luciferase Assay Substrate (Promega) and an Lmax lumi-
nescence microplate reader (Molecular Devices). For peptide inhibition
experiments, BSR cells were aliquoted into Eppendorf tubes containing
twofold serial dilutions of C-peptides before being overlaid onto the Vero
cells. The IC50 values of the peptides were estimated by fitting the experi-
mental data to the equation y   100   100   [(x/a) ^ k/(1   [x/a] ^ k)],
where y is average percentage of luciferase activity (from triplicate sam-
ples), x is the bulk concentration of peptide, k is a scaling constant, and a
is the IC50 value.
Lipidic and aqueous dye transfer
Human erythrocytes (RBCs) were single labeled with aqueous 6-CF (Mo-
lecular Probes, Inc.) or dual labeled with CF and the lipid probe octadecyl
rhodamine B chloride (R18; Molecular Probes). CV-1 cells grown on glass
coverslides were infected with vTF7-3 and transfected with pGEM DNA
for 4 h at 37 C, followed by 18 h at 33 C. To allow binding of the dye-
labeled RBCs but to prevent temperature-induced fusion, 1 ml ice-cold
0.1% hematocrit dye-labeled RBCs was added to each sample and the CV-
1/RBC (effector–target) complexes were incubated on ice at 4 C for 1 h. The
effector–target cell complexes were incubated at 37 C for 15 min to allow
dye transfer to take place, before washing five times with ice-cold PBS  to
remove unbound RBCs. Dye transfer was assessed by scanning confocal
microscopy (model LSM 410; Carl Zeiss MicroImaging, Inc.) and quantify-
ing CF or R18 dye transfer from labeled RBCs to CV-1 cells. To study syn-
cytium formation and HN-independent retention of RBCs, CV-1 effector
cells were labeled with 1  M SYTO-17 nucleic acid dye (Molecular
Probes, Inc.) at 37 C for 30 min, and single-labeled CF-RBCs were used as
fusion targets. For the temperature dependence of dye transfer, effector–
target complexes were incubated for 5 min at the reported temperatures
before washing with ice-cold PBS . For the kinetics of dye transfer, effec-
tor–target complexes were incubated at 37 C for the reported times before
washing with ice-cold PBS .
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